Immunome (NASDAQ: IMNM) is expected to announce its Q4 2025 earnings on Wednesday, March 18, 2025, before the market opens. Analysts predict the company will report...
REE Automotive (NASDAQ: REE) is set to announce its fourth-quarter earnings for the fiscal year 2025 on March 12, 2026, before the market opens. Analysts anticipate...
Focus Partners Advisor Solutions LLC has significantly increased its investment in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by an impressive 533% during the third quarter of 2023....
LightPath Technologies (NASDAQ: LPTH) has emerged as a stronger investment option compared to Axion Power International (OTCMKTS: AXPWQ) based on a detailed comparison of various financial...
Avidity Biosciences (NASDAQ:RNA) is preparing to release its fourth-quarter earnings for the fiscal year 2025 on February 26, 2026, before the market opens. Analysts anticipate that...
Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is scheduled to release its earnings report for the fourth quarter of 2025 on February 24, 2026, before the market opens....
Investment analysts have recently adjusted their ratings and price targets for shares of Microchip Technology (NASDAQ: MCHP), a semiconductor company based in Chandler, Arizona. These changes...
In a recent assessment of two small-cap medical companies, Trevi Therapeutics (NASDAQ: TRVI) and Zhengye Biotechnology (NASDAQ: ZYBT), analysts are weighing their relative strengths in various...
Golden Sun Health Technology Group Limited (NASDAQ: GSUN) experienced a substantial increase in short interest during January 2024. As of January 30, the total short interest...
Entrada Therapeutics (NASDAQ: TRDA) recently presented its strategic vision for 2026 at the Guggenheim 2026 Emerging Outlook Biotech Summit, highlighting a series of anticipated clinical data...
